Helius Medical Technologies's - HSDT market analysis on 26th November 2020

Transaction Date	Recipient	Shares	Type	Price	Value
21st October 2020	Dane Andreeff	37,363	Grant/award etc.	$0.46	$17,257.97
21st October 2020	Dane Andreeff	638,182	Grant/award etc.	$0.46	$294,776.27
21st October 2020	Dane Andreeff	134,873	Grant/award etc.	$0.46	$62,297.84
21st October 2020	Joyce N La Viscount	38,138	Grant/award etc.	$0.46	$17,615.94
21st October 2020	Dane Andreeff	371,883	Grant/award etc.	$0.46	$171,772.76
31st July 2020	Joyce N La Viscount	4,946	Grant/award etc.	$0.56	$2,745.03
15th July 2020	Joyce N La Viscount	5,312	Grant/award etc.	$0.52	$2,745.24
30th June 2020	Joyce N La Viscount	6,429	Grant/award etc.	$0.43	$2,764.47
15th June 2020	Joyce N La Viscount	5,602	Grant/award etc.	$0.49	$2,744.98
29th May 2020	Joyce N La Viscount	5,557	Grant/award etc.	$0.49	$2,722.93

Helius Medical Technologies

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.

Helius Medical Technologies, Inc. focuses on licensing and acquiring platform technologies that amplify the brain's ability to heal itself. The company was founded in 2014 and is headquartered in Newtown, PA.

Ticker: HSDT

Sector: Health Technology

Industry: Medical Specialties

SEC Central Index Key (CIK): 1610853

Employees: 19

Exchange: NASDAQ

Auditor Opinion:

You must Login to see Language Changes

Disclosure Language changes

Analysis of subtle changes in disclosure language. Red is a sign of more constrained, less positive language changes etc. Green is more positive, less constrained etc.

You must Login to see analysis